quinazolines has been researched along with Enlarged Spleen in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (80.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aksu, S; Büyükaşık, Y; Eliaçık, E; Göker, H; Haznedaroğlu, İC; Işık, A; Özcebe, OI; Sayınalp, N; Üner, A | 1 |
Alkindi, S; Dennison, D; Pathare, A | 1 |
Alferez, D; Goodlad, RA; Mandir, N; Poulsom, R; Pyrah, IT; Ryan, AJ; Smith, NR; Watkins, AJ; Wedge, SR; Wilkinson, RW | 1 |
Liu, D; Seiter, K; Yalamanchili, K | 1 |
Bennett, M; Chubar, E | 1 |
1 review(s) available for quinazolines and Enlarged Spleen
Article | Year |
---|---|
Pharmacobiological Approach for the Clinical Development of Ruxolitinib in Myeloproliferative Neoplasms.
Topics: Bone Marrow; Combined Modality Therapy; Disease Progression; Female; Fibrosis; Humans; Hydroxyurea; Janus Kinase 2; Leukapheresis; Middle Aged; Myeloproliferative Disorders; Nitriles; Phlebotomy; Point Mutation; Polycythemia Vera; Protein Kinase Inhibitors; Pyrazoles; Pyrimidines; Quinazolines; Splenectomy; Splenomegaly | 2015 |
4 other study(ies) available for quinazolines and Enlarged Spleen
Article | Year |
---|---|
Successful outcome with anagrelide in pregnancy.
Topics: Adult; Blood Cell Count; Female; Humans; Platelet Aggregation Inhibitors; Pregnancy; Pregnancy Complications, Hematologic; Quinazolines; Splenomegaly; Thrombocytosis | 2005 |
Inhibiting vascular endothelial growth factor receptor-2 signaling reduces tumor burden in the ApcMin/+ mouse model of early intestinal cancer.
Topics: Adenoma; Animals; Female; Genes, APC; Intestinal Neoplasms; Intestinal Polyps; Male; Mice; Mice, Inbred C57BL; Quinazolines; RNA, Messenger; Signal Transduction; Splenomegaly; Vascular Endothelial Growth Factor Receptor-2 | 2006 |
Myelofibrosis with a novel translocation, t(1;3)(q31;q23), and response to imatinib mesylate.
Topics: Antigens, CD; Benzamides; Bone Marrow Cells; Chromosomes, Human, Pair 1; Chromosomes, Human, Pair 3; Humans; Imatinib Mesylate; Male; Middle Aged; Piperazines; Primary Myelofibrosis; Protein Kinase Inhibitors; Pyrimidines; Quinazolines; Remission Induction; Splenomegaly; Translocation, Genetic | 2007 |
Chronic myeloid leukemia evolving after idiopathic myelofibrosis.
Topics: Adult; Blood Cell Count; Chromosomes, Human, Pair 22; Chromosomes, Human, Pair 9; Fibrinolytic Agents; Fusion Proteins, bcr-abl; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukocytosis; Male; Megakaryocytes; Primary Myelofibrosis; Quinazolines; Splenomegaly; Thrombocytopenia; Translocation, Genetic | 2007 |